Healome Therapeutics
Develops proprietary eye-drop matrix technology for ocular surface diseases
£2MSeed
Role not disclosedEV
Empirical Ventures
Activity from announced rounds
Activity in this selectionhealthworx-834921a0
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $6M 2 disclosed · full round size, not this investor’s share